Mohammad, Daisal A.
HRN: 23-35-77 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/18/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/18/2023
07/24/2023
IVT
300mg
Q8h
Open Joint Disclocation
Checking Final Appropriateness
Indication: ProphylaxisEmpiric Type of Infection: Bone & Joint Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes